Bad Homburg vor der Höhe
CEO stands down: Carla Kriwet is to stand down as CEO of German healthcare company Fresenius Medical Care after just two months owing to disagreements over strategy, “raising concern about the company’s commitment to a turnaround”, say Immanual John Milton and Tim Loh on Bloomberg. Finance chief Helen Giza will replace her and remain in her current role.
The “shake up” adds to the “list of uncertainties” surrounding the kidney-dialysis company. Michael Sen, the new CEO of parent entity Fresenius, said in October that it was carrying out a “top-to-bottom” review of all its businesses. The German healthcare conglomerate is “under pressure from [activist] investors”. Elliott Investment Management, which has a stake in Fresenius, has disclosed a short position in Fresenius Medical and could be seeking to break up the group. Fresenius’s “sprawling business” has been “misfiring” since the pandemic, says Aimee Donnellan in Breakingviews. During Covid-19, patients were reluctant to visit clinics and big construction projects were
